Sustained release matrix tablet of 100 mg losartan potassium: Formulation development and in vitro characterization
Braz. J. Pharm. Sci. (Online); 58 (), 2022
Abstract Sustained release matrix tablets of 100 mg losartan potassium HCl were fabricated with two
release retarding polymers namely HPMC K100 M and affinisol by direct compression method.
Nine trial formulations were prepared by varying content of these polymers, each from 50 mg
to 100 mg; keeping the...